C99-92182-96745
3 vaccinations
3 coded responses
36 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 989 / WA
- Registered
- 2020-12-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-31
Registered in v-safe
-
2020-12-31
Dose 1 — Moderna
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-05
- 2021-01-06
- 2021-01-07
- 2021-01-17
- 2021-01-21
-
2021-01-28
Dose 2 — Moderna
- 2021-01-28
-
2021-01-29
Survey response — days 1–6 daily, dose 2MedDRA: Dizziness — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: DizzinessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-30
- 2021-02-01
- 2021-02-03
- 2021-02-11
- 2021-02-18
- 2021-02-26
- 2021-03-04
- 2021-03-13
- 2021-04-29
- 2021-07-29
-
2021-11-19
Dose 3 — Moderna
-
2021-11-20
Survey response — days 1–6 daily, dose 3MedDRA: Decreased appetite — Feeling: Fair · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Loss of appetiteMedDRA releases: 2024-11 · check-in free text available
- 2021-11-21
- 2021-11-22
- 2021-11-23
- 2021-11-24
- 2021-11-25
- 2021-11-26
- 2021-12-03
- 2021-12-10
- 2021-12-17
- 2021-12-24
- 2021-12-31
-
2022-02-18
Survey response — 3 months, dose 3MedDRA: Fatigue, Respiratory tract congestion, Sinus pain — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Sinus pain, congestion and fatigueMedDRA releases: 2024-11 · check-in free text available
-
2022-02-18
Report sent to call center — 3 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-02-23
- 2022-05-22
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-31 | Moderna | |
| 2 | 2021-01-28 | Moderna | |
| 3 | 2021-11-19 | Moderna | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 3 — days 1–6 daily, dose 2
Systemic reaction (other): Dizziness
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Loss of appetite
Release 11 — 3 months, dose 3
Symptoms: Sinus pain, congestion and fatigue
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Sinus pain | · | · | ✓ |
| SRO | Decreased appetite | · | · | ✓ |
| SRO | Dizziness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release